Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06195605 · ClinicalTrials.gov registry record · NA
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
A NA study of Photoaging, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06195605: Recruiting NA study of Photoaging, sponsored by University of Michigan.
NCT06195605 is a NA study of Photoaging that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 15 participants, below the 31-participant average among 14 other Photoaging trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06195605, a NA study of Photoaging, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the impact of the injection of dermal filler on the quality of the skin dermal extracellular matrix in persons between the ages of 30-50 years. The quality of the dermal extracellular matrix will be assessed following injection of dermal filler compared to injection of saline vehicle.
Primary Outcome
Reported as a semi-quantitative grade. The grading scale is 1-4. The higher the number to increased ECM deposition.
Conditions Studied
Interventions
- DEVICE Restylane-L
- DEVICE Vehicle
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT06195605 shows while recruiting
NCT06195605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 31-participant average among 14 other Photoaging trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 2 interventions - of which Restylane-L is the first listed.
NCT06195605 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06195605 about?
NCT06195605 is a clinical study titled "Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin". The purpose of the study is to investigate the impact of the injection of dermal filler on the quality of the skin dermal extracellular matrix in persons between the ages of 30-50 years. The quality of the dermal extracellular matrix will be assessed following injection of dermal filler compared to ...
What is the current status of trial NCT06195605?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-05-09. Estimated completion is 2026-11.
What conditions does trial NCT06195605 study?
This clinical trial studies the following conditions: Photoaging.
What interventions are being tested in trial NCT06195605?
The interventions under investigation include: Restylane-L (DEVICE), Vehicle (DEVICE).
Who is sponsoring clinical trial NCT06195605?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06195605 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photoaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06195605's enrollment target sits among peer trials
15 14th of 14 higher than 1 of 14 other Photoaging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Photoaging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
COMPLETED · NA
-
Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
COMPLETED · NA
-
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
COMPLETED · NA
-
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI